,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny,breast,4', 'breast', 'destiny-04']
destiny-04 data will change #breastcancer care today. listen to and discuss the data and what it means for patients. #asco22 
Oncology and HCP editorial lead @RemHealthMedia, OBRoncology and @PatientPower. Science and medical writer, former bench scientist. Tweets are my own. She/her